Questions about neurological disorders
Are extracellular vesicles useful biomarkers for neurological disorders and heart disease?
Extracellular vesicles (EVs) are promising biomarkers for neurological disorders and heart disease because they carry molecular signals from the brain and heart into the blood, allowing for non-invasive testing.
Full answer →Can extracellular vesicles help diagnose neurological disorders like cancer?
Extracellular vesicles (EVs) act as promising biomarkers for neurological disorders like Alzheimer's and Parkinson's, offering a less invasive way to detect disease signals in blood or other fluids.
Full answer →All neurological disorders Articles
- Digital neurorehabilitation improvements in virtual environments do not consistently translate to real-world functional gains
- B-cell depletion and S1P inhibitors significantly reduce mRNA vaccine binding antibody levels in immunocompromised patients
- Herbal medicines and phytoconstituents modulate vagus nerve activity and cholinergic neurotransmission in animal models
- Curcumae Radix shows antitumor, hepatoprotective, and anti-inflammatory effects in systematic review
- Transcutaneous auricular vagus nerve stimulation mechanisms and parameter optimization reviewed
- Narrative review discusses extracellular vesicles as biomarkers for cancer, neurological disorders, and cardiovascular diseases
- Tai Chi reduces inflammatory gene expression in chronic disease patients
- Demographics and visit factors associated with patient cycle time in a Saudi cohort of 52,611 visits
- Chronic Insomnia in Hospitalized Adults: Associated Conditions and Metabolic Abnormalities
- FEES Dysphagia Index (FDI) derivation and validation in hospitalized neurological patients
- Review of UK Biobank data identifies plasma protein mediators in cardiometabolic disease progression
- Telemedicine network associated with lower 90-day mortality and care needs in rural acute neurological disorders
- Video consultations reduced symptom burden in palliative neurological care compared to treatment as usual
- Review examines automated ventricular segmentation from MRI for neurological disease insights